Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Krautter

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Immunology|January 22, 2025
Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomesChristoph F Mahler, Felix Friedl, Christian Nusshag, et al.
Transplantation|January 10, 2024
Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation StudyFriedrich A von Samson-Himmelstjerna, Nassim Kakavand, Charlotte Gleske, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Frontiers in Immunology|January 22, 2025
Evaluation of deceased-donor kidney offers: development and validation of novel data driven and expert based prediction models for early transplant outcomesChristoph F Mahler, Felix Friedl, Christian Nusshag, et al.
Transplantation|January 10, 2024
Potential and Uncertainties of RejectClass in Acute Kidney Graft Dysfunction: An Independent Validation StudyFriedrich A von Samson-Himmelstjerna, Nassim Kakavand, Charlotte Gleske, et al.
Frontiers in Immunology|July 24, 2023
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantationMatthias Schaier, Christian Morath, Lei Wang, et al.
Pageof 3